Assembly Biosciences, Inc.
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as co…
Biotechnology
US, South San Francisco [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Assembly Biosciences, Inc. has no acquisition track records yet.
M&A Deals · History
Assembly Biosciences, Inc. has no acquisition track records yet.